Koninklijke Philips NV Cedear PHG
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 1.84
- Price/Sales
- 0.13
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 1.77%
Company Profile
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal care products.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Large Core
- Total Number of Employees
- 68,701
- Website
- https://www.philips.com
Competitors
Valuation
|
Metric
|
PHG
|
SHL
|
RMD
|
|---|---|---|---|
Price/Earnings (Normalized) | 1.84 | 24.04 | 29.12 |
Price/Book Value | 0.13 | 3.18 | 6.93 |
Price/Sales | 0.13 | 2.62 | 7.09 |
Price/Cash Flow | 1.81 | 20.61 | 24.49 |
Price/Earnings
PHG
SHL
RMD
Financial Strength
|
Metric
|
PHG
|
SHL
|
RMD
|
|---|---|---|---|
Quick Ratio | 0.66 | 0.79 | 1.18 |
Current Ratio | 1.16 | 1.27 | 2.59 |
Interest Coverage | 0.15 | 6.36 | 28.67 |
Quick Ratio
PHG
SHL
RMD
Profitability
|
Metric
|
PHG
|
SHL
|
RMD
|
|---|---|---|---|
Return on Assets (Normalized) | 4.12% | 4.04% | 16.71% |
Return on Equity (Normalized) | 10.11% | 10.35% | 25.48% |
Return on Invested Capital (Normalized) | 6.98% | 11.27% | 20.37% |
Return on Assets
PHG
SHL
RMD
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Nxhmcsx | Twhqmj | $196.0 Bil | |||
| Stryker Corp
SYK
| Tfqpxtlb | Mxwm | $133.8 Bil | |||
| Boston Scientific Corp
BSX
| Gqgbsjzbt | Gylqm | $124.5 Bil | |||
| Medtronic PLC
MDT
| Kgvxfbtn | Czbjzcf | $113.2 Bil | |||
| Edwards Lifesciences Corp
EW
| Ncgdmjljn | Sztggb | $39.5 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Pzqlk | Dky | $30.2 Bil | |||
| DexCom Inc
DXCM
| Sjltrgzkl | Jklb | $27.3 Bil | |||
| Steris PLC
STE
| Xnlvytxwq | Hmmfx | $22.8 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Bxwlhjjjw | Gsmvx | $21.3 Bil | |||
| Insulet Corp
PODD
| Fchthwxpcc | Gtgtxjq | $16.1 Bil |
United States